Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'Active Transdermal Delivery' returned 125 results - Page 1 of 7   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Active Transdermal Delivery Systems: Evolving Technology, Expanding Opportunities   Greystone Associates, Feb 2011 molecular size limit dramatically, opening up a host of opportunities for transdermal delivery. Highlights - Analyzes and evaluates active transdermal device technology and commercial active transdermal Transdermal Pain Management to 2015: Markets, Demand Factors, Opportunities and Forecasts   Greystone Associates, Dec 2010 vs Active Delivery Systems - Transdermal Pain Management Gels - Transdermal Formulations - IP and Proprietary Technology - Limitations of Topical Gels Transdermal Pain Management Product Assessments Transdermal CNS Therapeutics: Products, Pipeline Candidates, Markets, Forecasts   Greystone Associates, June 2011 and Packaging - The Patch Manufacturing Ecosystem - CNS Patch Economics - Passive vs Active Delivery Systems The Global Market for Transdermal CNS Therapeutics –Disease Segment Analysis - ADHD - Alzheimer The Top 50 Transdermal Drug Delivery Technology Companies Worldwide   Research Facts Ltd, Jan 2011, Pages: 142 employ active delivery, in which the stratum corneum is breached to enhance the permeability of the skin. These active transdermal technologies include iontophoresis, electroporation, microneedles Prescription Drug Patches to 2015: Products, Indications, Markets and Opportunities   Greystone Associates, Aug 2011 Transdermal drug patches offer the advantages of ease of use, painlessness, disposability, control of drug delivery and avoidance of first-pass metabolism by the liver. Advances in synthetic Next Generation Transdermal Drug Patches: Evolving Technology, Emerging Opportunities   Greystone Associates, Aug 2011 Transdermal drug patches offer the advantages of ease of use, painlessness, disposability, control of drug delivery and avoidance of first-pass metabolism by the liver. Advances in synthetic 2008 U.S. Drug Delivery: Neurological Disorders - Physician Perspective   Frost & Sullivan, Nov 2010, Pages: 45 transdermal patch, active transdermal, and implant delivery methods. Market Sectors Expert Frost & Sullivan analysts thoroughly examine the following market sectors in this research: - Autoinjectors The Top 40 Transdermal Drug Delivery Technology Companies Worldwide   Research Facts Ltd, July 2009, Pages: 98 years, the transdermal route of drug delivery has evolved considerably and it now competes with oral treatment. A number of transdermal technologies have been developed which employ active delivery Iontophoresis Drug Delivery: Devices, Drugs and Therapeutic Prospects   Greystone Associates, May 2011 To expand the limits of transdermal drug delivery, developers are employing energy sources such as ultrasound, heat and electrical current to affect active transport through the skin Drug Self-Administration Markets to 2016   Greystone Associates, Jan 2012 Transdermal Patch Design Passive Patch Construction Active Transport Patch Technologies Iontophoresis Electroporation Microporation Mechanical Arrays Radio Frequency Thermal/Heat Ultrasound Prescription Transdermal Skin Patches: Markets and Opportunities 2009   Greystone Associates, March 2009, Pages: 180 , skin patches are rapidly becoming an important consumer healthcare product category. Transdermal drug patches offer the advantages of ease of use, painlessness, disposability, control of drug delivery Insulin Patch Pumps: Devices, Markets, Players and Prospects   Greystone Associates, Nov 2011 a transdermal drug device format with an active delivery technology. Provider organization business managers, healthcare administrators and investors will also benefit from this study. Executive Summary Fentanyl - Products, Markets, Strategies and Opportunities   Greystone Associates, Nov 2011 effectiveness against breakthrough pain and has become a commonly prescribed pain medication for most forms of cancer. Controlled release formulations that include transdermal patches and transmucosal tablets Drug Delivery Technologies - Current Market Dynamics, Future Market Opportunities and Lifecycle Strategies   Arrowhead Publishers, Sep 2008, Pages: 283 .5 TRANSDERMAL DRUG DELIVERY 2.5.1 Passive Formulations 2.5.2 Active Formulations 2.6 NICHE TECHNOLOGIES 2.6.1 Topical Systems 2.6.2 Gene Delivery 2.6.3 Implantable Systems 2.6.4 Drug Delivery Microchips 2 U.S. Transdermal Drug Delivery Markets   Frost & Sullivan, Aug 2006 This Frost & Sullivan research service entitled U.S. Transdermal Drug Delivery Market provides pipeline analysis, forecasts, and technology overviews. In this research, Frost & Sullivan's expert Drug Delivery Innovations Driving Improved Patient Compliance   Business Insights, July 2011, Pages: 147 , the transdermal administration route is attracting the most attention. Across all parenteral delivery forms, the continued increase in the number of experimental protein and peptide drug candidates means Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies   Jain PharmaBiotech, Feb 2012, Pages: 345 Nasal delivery of neuroprotective drugs for stroke Transdermal drug delivery for neurological disorders Drug delivery to the brain via inner ear Invasive neurosurgical approaches Intraarterial drug Drug Delivery in Cancer - Technologies, Markets and Companies   Jain PharmaBiotech, Feb 2012, Pages: 639 gefitinib vs intravenous docetaxel Transdermal drug delivery Delivery of the photosensitizer drug d-amino levulinic acid Transdermal delivery of the methotrexate Transdermal nitroglycerine for prostate Handbook of Non-Invasive Drug Delivery Systems. Science and Technology   Elsevier Science and Technology, Dec 2009, Pages: 328 -passive, transdermal-active (device- aided enhanced penetration), trans-mucosal membrane, trans-ocular membrane as well as delivery via alveolar membrane from inhaled medication. Patient compliance has been Nanobiotechnology Applications, Markets and Companies   Jain PharmaBiotech, Feb 2012, Pages: 772 penetration is improved in transdermal drug delivery. A particularly effective application is as nonviral gene therapy vectors. Nanotechnology has the potential to provide controlled release devices Results:  First -   Prev -   1 -   2 -   3 -   4 -   5 -   6 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-800-526-8630 (US/Canada Toll Free)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets3    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network